Clinical Trials Logo

Filter by:
NCT ID: NCT05142696 Recruiting - Clinical trials for Extensive Stage Small Cell Lung Cancer

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Start date: July 13, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This study aims to establish a safe and well tolerated dose of [177Lu]Lu-DOTA-TATE in combination with carboplatin, etoposide and atezolizumab in this setting and to assess preliminary efficacy of this combination treatment versus the combination of carboplatin, etoposide, and atezolizumab.The study will be essential to assess a new potential therapeutic option in participants with this aggressive cancer type.

NCT ID: NCT05142462 Active, not recruiting - Hip Fractures Clinical Trials

Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup

Start date: October 27, 2021
Phase:
Study type: Observational

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

NCT ID: NCT05142410 Completed - Pregnancy Related Clinical Trials

Understanding Post-translational Modifications to Circulating Histones Via Mass Spectrometry in Pregnant Women Developing Pre-eclampsia: A Retrospective Study

GHISPE
Start date: March 1, 2019
Phase:
Study type: Observational

This is a descriptive pilot study on a ready-constituted biobank (outside the Jardé Law). It is an ancillary study to the "GrossPath" cohort (RCB ID number: 2014-A01120-47). Pregnancy generates an increased risk of thrombosis, and placenta-mediated diseases constitute a risk factor for cardiovascular pathologies responsible for significant maternal-fetal morbidity and mortality. Understanding and exploring the cellular and molecular mechanisms of dysfunctions of the vascular-placental interface could provide arguments to understand the systemic vascular risk, characterize it and finally detect it on the basis of new markers, thus opening the way for targeted preventive management to reinforce the general principles of precision medicine. Netosis is a process of activation of neutrophils, which then generate filaments containing DNA, enzymes and extracellular histones. Netosis occurs in pregnancy and is increased in vascular-placental complications. It can be studied by measuring circulating histones, particularly the citrullinated histone H3. Levels of this modified histone H3, as well as those of two other modifications, have recently been shown to increase during pregnancy. These levels have also been shown to be even greater in pregnancy complications. The aim of this study is to complete this mapping in order to obtain a precise signature for all post-translational histone modifications in normal pregnancies and pregnancies complicated by pre-eclampsia from the "GrossPath" cohort in order to propose new circulating biomarkers for placental vascular pathologies. The post-translational histone modification profiles (mapping) of pregnant women with normal pregnancies will be compared with those developing pre-eclampsia.

NCT ID: NCT05142293 Recruiting - Heart Failure Clinical Trials

One Day Implantation Program for Heart Failure Patients Implanted With CRT-P

OEDIPE-CRT-P
Start date: December 6, 2021
Phase:
Study type: Observational

This study has been implemented to evaluate cardiac resynchronization therapy pacemaker (CRT-P) implantations on a same-day basis

NCT ID: NCT05142059 Active, not recruiting - Clinical trials for Charcot-Marie-Tooth Type 1A Neuropathy

Fall Risk Assessment in a Population of Charcot-Marie-Tooth Disease Type 1A (CMT 1A) by Timed Up and Go Test

DeteCTCMT
Start date: September 3, 2020
Phase: N/A
Study type: Interventional

The main objective of this study is to explore the relationship between the onset of fall and the time taken to complete the Timed Up and Go test (TUG) in this CMT1A patient population. The investigators hypothesize that patients with balance disorders and therefore a risk of major fall will require a longer time to perform the Timed Up and Go test. In addition, it seems important to confirm that the severity of the disease has a negative impact on the frequency of balance disorders.

NCT ID: NCT05141383 Recruiting - Prostate Cancer Clinical Trials

Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy

HOPE
Start date: May 4, 2022
Phase: N/A
Study type: Interventional

Constitution of a biological collection within the framework of the establishment of a diagnostic, prognostic and active surveillance test for prostate cancer from long non-coding RNA biomarkers, in 3 cohorts of patients, with cancer of the prostate, with suspected cancer without biopsy confirmation or with prostatic hyperplasia and healthy donors. This biological collection will also be used as a support for further researches on the identification of biomarkers and genetic markers to improve the prognosis and diagnostic management of patients with prostate pathologies.

NCT ID: NCT05141370 Completed - Cataract Surgery Clinical Trials

Assessment of a Femtosecond Laser to Perform Capsulorhexis During Cataract Surgery

Start date: February 3, 2022
Phase: N/A
Study type: Interventional

This study is a Pre-market first-in-man clinical investigation to validate performance of a hand-held femtosecond laser named CATSYS.

NCT ID: NCT05141123 Completed - Aneurysm Abdominal Clinical Trials

Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures

Start date: October 30, 2022
Phase:
Study type: Observational

The aim of the study is to evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms. Results and postoperative events are reported in accordance with the current reporting standards for endovascular aortic repair prepared and revised by the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery. The Registry will include approximately 300 patients treated from January 2015 to May 2021 (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be extended until June 2026.

NCT ID: NCT05140980 Recruiting - Sexual Behavior Clinical Trials

Sexuality Education: Knowledge of Women Aged 18 to 25

EDUSEX
Start date: November 1, 2021
Phase:
Study type: Observational

Information, education and communication concerning sexual health are essential for enable to do informed and responsible decisions about it. In France, education for sexuality in schools still remains unequal and is considered as unsuited to the realities of young people. This observation led to the development of a national sexual health strategy. One of the challenges is to promote and enhance the implementation of interdisciplinary sexuality education. Midwives are and should be involved in the issue of sexuality.

NCT ID: NCT05140473 Completed - Nurses's Workload Clinical Trials

Identification of the Determinants of the Perceived Workload of Nurses

CHARMIREA
Start date: June 20, 2022
Phase:
Study type: Observational

The purpose of this study is to identify the determinants of the perceived workload of intensive care and pediatric continuous monitoring nurses (factors liked to the care service, staff, patients treated)